miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression

Background: Sorafenib appears to increase the survival rate of hepatocellular carcinoma (HCC) patients, but its response rate is seriously limited due to drug resistance. Molecular mechanisms underlying sorafenib resistance are still unknown. Herein, we explored the possible role of miR-1226-3p in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xianqing, Tan, Wenliang, Li, Wenxin, Li, Wenda, Zhu, Sicong, Zhong, Jinyi, Shang, Changzhen, Chen, Yajin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584923/
https://www.ncbi.nlm.nih.gov/pubmed/31258782
http://dx.doi.org/10.7150/jca.31804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584923/
https://www.ncbi.nlm.nih.gov/pubmed/31258782
http://dx.doi.org/10.7150/jca.31804

Ejemplares similares